and pellets seperated. The pellets of membranes and nuclei werewashed with the same buffer with gentle homogenization. Aftercentrifugation the wash (second supernatants) was combined withthe forst supernatants and the nuclei-membrane pellets removed.Nucleic acids were removed from the supernatant fractions bysuccessive precipitations with MnCl2 and...[One of dozens of publications authored by Robert C. Gallo andcolleagues affiliated with Bio<strong>net</strong>ics Research Laboratories,Bio<strong>net</strong>ics, or Litton Bio<strong>net</strong>ics. These subsidiaries of LittonIndustries, Inc. were listed among most frequently contractedcompanies involved in biological weapons research anddevelopment during the 1960s and 1970s. [20,21] Source: GalloRC, Yang SS and Ting RC. RNA Dependent DNA Polymeraseof Human Acute Leukaemic Cells. Nature 1970; 228:927.]- - - - -Fig 6.7 - Major United States Army Biological WeaponsContractors for Fiscal year 1969:Mr. Mahon. List for the record the major contractors and thesums allocated to them in this program in fiscal year 1969.(The information follows:)The following list contains the major contractors and amounts ofeach contract.ContractorFiscal year 1969Miami, University of Coral Gables Fla$645,000Herner and Co., Bethesda. Md$518,000Missouri, University of, Columbia, Mo$250,000Chicago, University, of Chicago, Ill$216,000Aerojet-General Corp,. Sacramento, Calif$210,000Bio<strong>net</strong>ics Research Laboratories, Inc., Falls Church, Va$180,000West Virginia Univercity. Morgantown, W. Va$177,000Maryland. University of, College Park. Md$170,000Dow Chemical Co., Midland, Mich$158,000Hazelton Laboritories, Inc., Falls Church, Reston. Va$145,000
New York University Medical Center, New York, NY$142,000Midwest Research Institute. Kansas Clty, MO$134.000Stanford University, Palo Alto, Califf$125,000Stanford Research Institute, Menio Park, Califf$124,000Pfizer and Co., Inc., New York, NY$120.000Aldrich Chemical Co., Inc., Milwaukee, Wis$117,000Computer Usahe Development Corp., Washington, D.C.$110,000New England Nuclear Corp., Boston, Mass$104,000Source: Department of Defense Appropriations For 1970:Hearings Before A Subcommittee of the Committee onAppropriations House of Representatives, Ni<strong>net</strong>y-first Congress,First Session, H.B. 15090, Part 5, Research, Development, Testand Evaluation of Biological Weapons, Dept. of the Army. U.S.Government Printing Office, Washington, D.C., 1969, p689.- - - - -Fig 6.8 - The Early Research of Cr. Robert Gallo at the NationalCancer Institute and it's Implications in relation to the Theory ofsynthetic HIV Development:PENDING- - - - -‐NOTES‐[1] Germain RN. Antigen processing and CD4+ T cell depletionin AIDS. Cell 1988; 54:441-414.[2] Herrera F. Adamson RH and Gallo RC. Uptake of transferribonucleic acid by nonnal and leukemic cells. Proc Nat Acad Sci1970;67;4: 1943-1950. This paper was presented before the"International Symposium on Uptake of Informative Moleculesby Living Cells, Mol, Belgium, 1970," the year in which $10million in funds were appropriated by the Department of Defensefor the development of AIDS-like viruses.[3] Gallo RC, Perry S and Breitman RT. The enzymaticmechanisms for deoxythymidine synthesis in human leukocytes.Journal of Biological Chemistry 1967;242;21:5059-5068.[4] Gallo RC and Perry S. Enzymatic abnormality in humanleukaemia. Nature 1968;218:465-466.
- Page 2 and 3:
EMERGING VIRUSES: AIDS &EBOLANature
- Page 4 and 5:
inherent in the production of live
- Page 6 and 7:
natural barrier and has been shown
- Page 8 and 9:
"DAVID was an alcoholic, an active
- Page 10 and 11:
mass of circumstantial and scientif
- Page 12 and 13:
investigators, for a grossly uninfo
- Page 14 and 15:
NIAID-National Institute for Allerg
- Page 16 and 17:
Part IIntroduction and Scientific B
- Page 18 and 19:
viruses in the cow carcasses used t
- Page 20 and 21:
depend to maintain our relative fre
- Page 22 and 23:
ʺThe WHO Does What?ʺ"The only thi
- Page 24 and 25:
the buildup of new susceptibles in
- Page 26 and 27:
In 1964, shortly after President Ke
- Page 28 and 29:
lymphotrophic (lymph-cell-targeting
- Page 30 and 31:
immunological and therapeutic proce
- Page 32 and 33:
substances used in the diagnosis of
- Page 34 and 35:
Chronicle 1969;23;3:112-117.[20] Si
- Page 36 and 37:
In February 1967, as international
- Page 38 and 39:
experiments conducted at Porton, En
- Page 40 and 41:
technique, weapon, tactic, or strat
- Page 42 and 43: mankind in general, require that th
- Page 44 and 45: experimental studies is to be comme
- Page 46 and 47: the virus genome, the genetic makeu
- Page 48 and 49: [17] Horowitz LG and Kehoe L. Fear
- Page 50 and 51: Chapter 4The Road to Fort Detrick R
- Page 52 and 53: information, I decided to call the
- Page 54 and 55: contamination) to help with manufac
- Page 56 and 57: nation. There is but one logical co
- Page 58 and 59: each part in terms of objectives -
- Page 60 and 61: weapons, and all other methods of b
- Page 62 and 63: two checks totaling $33,655.68 to t
- Page 64 and 65: Not surprisingly then, among the pr
- Page 66 and 67: and biological warfare. Indianapoli
- Page 68 and 69: Chapter 5The Emperorʹs New Virus"Y
- Page 70 and 71: At that time, retroviruses were see
- Page 72 and 73: it up to here with this goddamn dis
- Page 74 and 75: Collusion at the TopJim Goedert was
- Page 76 and 77: HTLV-III publication in Francis's p
- Page 78 and 79: the footprints of a retrovirus allo
- Page 80 and 81: questions. Had Gallo been ashamed o
- Page 82 and 83: Chapter 6Galloʹs Research Antholog
- Page 84 and 85: - - - - -Fig 6.2 - A Model of the N
- Page 86 and 87: That same year, Gallo and his cowor
- Page 88 and 89: team discussed the synthesis of new
- Page 90 and 91: STRINGNER S. YANGROBERT C. TINGBion
- Page 94 and 95: [5] Gallo RC and Breitman TR. The e
- Page 96 and 97: Chapter 7An Interview with Dr. Robe
- Page 98 and 99: human viruses, and that the genetic
- Page 100 and 101: LEN: Now, who was studying that?ROB
- Page 102 and 103: father's recommendation that I coul
- Page 104 and 105: LEN: OK. Explain this now. Why did
- Page 106 and 107: the cancer virus. . . . Nixon was t
- Page 108 and 109: LEN: OK.ROBERT: And. . . that's the
- Page 110 and 111: ROBERT: If you look in the world, w
- Page 112 and 113: ROBERT: They're in the references [
- Page 114 and 115: started with BVV.ROBERT: Well, in t
- Page 116 and 117: LEN: OK. So what happens then?ROBER
- Page 118 and 119: apology Gorbachev offered Reagan ac
- Page 120 and 121: slowly, and not fast. And that they
- Page 122 and 123: immunodeficiency virus. Nature 1987
- Page 124 and 125: GalloRC. Aminoacyl Transfer RNA Pro
- Page 126 and 127: history, organization, and program